AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy: Communication

Clin Gastroenterol Hepatol. 2024 Apr;22(4):705-707. doi: 10.1016/j.cgh.2023.11.002. Epub 2023 Nov 7.

Abstract

Description: The purpose of this American Gastroenterological Association (AGA) Institute Rapid Clinical Practice Update (CPU) Communication is to review the available evidence and provide expert advice regarding the evolving management of patients taking GLP-1 receptor agonists prior to endoscopy.

Methods: This CPU was commissioned and approved by the AGA Institute Clinical Practice Updates Committee (CPUC) and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership and underwent internal peer review by the CPUC and external peer review through standard procedures of Clinical Gastroenterology and Hepatology. This communication incorporates important and recently published studies in this field, and it reflects the experiences of the authors who are experts in bariatric medicine and/or endoscopy.

Keywords: Anesthesia; Glucagon-like peptide; Ozempic; Sedation; Semaglutide; Wegovy.

Publication types

  • Practice Guideline

MeSH terms

  • Endoscopy, Gastrointestinal
  • Gastroenterology*
  • Glucagon-Like Peptide-1 Receptor Agonists*
  • Humans
  • United States

Substances

  • Glucagon-Like Peptide-1 Receptor Agonists